Free radicals have been shown to play an important role in ischemia-reperfusion injury in several organ systems; however, the role of free radicals in central nervous system ischemia has been less well studied. Many potential free radical-generating systems exist. The primary products of these reactions, superoxide and hydrogen peroxide, may combine to produce hydroxyl radicals. Of the many potential sources of free radical generation, the enzyme xanthine oxidase has been shown to be important in ischemia in noncerebral tissue. We investigated the effect of the hydroxyl radical scavenger dimethylthiourea and the xanthine oxidase inhibitor allopurinol on infarct volume in a model of continuous partial ischemia. Male Sprague-Dawley rats were treated with dimethylthiourea or allopurinol before middle cerebral artery occlusion. Infarct volume was measured by triphenyltetrazolium chloride staining of brains removed 3 or 24 hours after occlusion. Stroke volume was reduced by 30% after dimethylthiourea treatment and by 32-35% after allopurinol treatment. At 24 hours after stroke, cortical tissue was more effectively protected than caudate tissue with both agents. Pretreatment with dimethylthiourea and allopurinol also significantly reduced cerebral edema formation and improved blood-brain barrier function as measured by fluorescein uptake. Our results imply that hydroxyl radicals are important in tissue injury secondary to partial cerebral ischemia and that xanthine oxidase may be the primary source of these radicals. (Stroke 1989;20:488-494)
F ree radicals have been implicated in ischemic
injury in a variety of organ systems. 1 These highly reactive compounds are capable of directly modifying or destroying many cellular components. In particular, they appear to propagate the cycle of lipid peroxidation that accompanies ischemia and to injure specific membrane-associated proteins. 2 -5 Membrane injury increases permeability to normally excluded compounds that may further damage cells. Interruption of this cascade by pretreatment with various free radical scavengers has resulted in significant tissue salvage in models of intestinal, 6 cardiac, 5 -7 and renal 8 ischemia.
In ischemia, there are many potential sources of free radicals, including xanthine oxidase, cyclooxygenase, lipoxygenase, mitochondrial enzymes, and activated neutrophils. 129 Some of these systems produce small quantities of toxic oxygen species even under normoxic conditions. However, during periods of hypoxia or ischemia, enzyme modification may occur or specific precursors may accumulate such that resupply of oxygen results in a significantly increased level of oxygen radical production. For this reason, free radical effects have been primarily studied in models of ischemia with reperfusion. There have been few studies of free radical production during partial ischemia.
McCord 1 has suggested that xanthine oxidase is the primary free radical-generating enzyme in cases of ischemia-reperfusion. He and others 10 " have shown that allopurinol (AP), an inhibitor of this enzyme, is as effective as free radical scavengers in limiting tissue injury. Betz 12 has shown that xanthine oxidase activity is present in the brain and that this activity is fourfold greater in capillary isolates relative to whole brain. If this enzyme is involved in ischemic cerebral injury, it is well positioned to produce endothelial cell damage that could lead to further tissue injury through alterations in cerebral blood flow and blood-brain barrier (BBB) function.
Free radicals and xanthine oxidase have been most thoroughly investigated in organ systems other than brain. However, free radicals are believed to contribute to brain injury, 31314 and free radical scavengers have been used to limit cerebral injury in ischemia and trauma. 1516 Two previous reports in models of cerebral ischemia-reperfusion have implicated xanthine oxidase as a possible source of free radicals in brain. 1718 We report the effect of AP, a xanthine oxidase inhibitor, and dimethylthiourea (DMTU), a hydroxyl radical scavenger, in a model of continuous partial cerebral ischemia.
Materials and Methods
Male Sprague-Dawley rats weighing 300-350 g were treated with either 750 mg/kg DMTU or 100 mg/kg AP. Solutions of both drugs were made fresh on the day of use. Ten rats received 100 mg/ml i.p. DMTU in normal saline vehicle 1 hour before middle cerebral artery occlusion (MCAO). Ten control (vehicle-treated) rats received saline only. The individual performing the MCAO was blinded to treatment. AP was given intragastrically as a suspension in 2% carboxymethylcellulose (CMC) vehicle. Regardless of the planned time of sacrifice, AP-treated rats were first exposed to the drug 48 hours before MCAO and received two more doses of AP in CMC 24 and 1 hours before MCAO. Control (vehicletreated) rats received CMC alone at the same times. AP-treated and control groups at each of two postischemic times consisted of 10 rats each.
A 10-mm segment of the right middle cerebral artery (MCA) was occluded by the method of Bederson et al. 19 Briefly, rats were anesthetized with 50 mg/kg i.m. ketamine and 10 mg/kg i.m. xylazine. A vertical incision was made midway between the right eye and ear. The temporalis fascia was incised, and the muscle was divided in the plane of its fibers. The zygoma was divided at its posterior attachment to the skull. A craniectomy was carried out using a dental drill. The dura mater was incised, and the arachnoidea was carefully stripped from the MCA. The MCA was occluded from a point 3-4 mm proximal to the olfactory tract to the inferior cerebral vein using bipolar cautery. The craniectomy was covered with oxidized cellulose, and the fascia and skin were closed. From the induction of anesthesia until the rats were fully awake, body temperature was monitored by a rectal probe and maintained at 37±1°C with a heating pad. Rats had free access to food and water throughout the pretreatment and recovery periods. Duplicate sham-occluded rats were studied for each treatment and control group. In these rats, MCAO was carried out to the point of arachnoidea stripping. Sham-occluded rats were otherwise handled identically to those of the experimental groups. DMTU-treated rats and their saline-treated controls were killed 24 hours after MCAO; AP-treated rats and their CMC-treated controls were killed 3 or 24 hours after MCAO. Before they were killed, the rats were anesthetized again with ketamine and xylazine. A left femoral artery cannula was placed. Blood pressure and rectal temperature were recorded, and blood was obtained for determination of hematocrit, serum osmolality, arterial pH, Paco^, and Pac>2. The rats were then decapitated. In six CMCtreated and six AP-treated rats in the 3-hours group, 0.3 ml/kg i.v. of a 1% sodium fluorescein solution was administered 15 minutes before decapitation.
Brains were quickly removed and chilled in a freezer. After adequate chilling, 10 1-mm coronal slices were taken using a tissue slicer (Stoelting Co., Chicago, Illinois); sectioning commenced 2 mm from the anterior pole. Slices were placed in a solution containing 1% triphenyltetrazolium chloride (TTC) and 25 mM potassium phosphate (pH 7.4) and turned every 15 minutes. After 45 minutes, both faces of each slice were photographed. For the 12 fluorescein-treated rats, both faces of each slice were immediately photographed under ultraviolet light using a filter to exclude light below a wavelength of 500 m/i before staining them with TTC. Sham-occluded rats treated with fluorescein showed virtually no staining at the craniectomy defect.
The unstained area in each photograph was quantified using computer-assisted planimetry (software by Jandel Science, Corte Madera, California). Before planimetry, the photographs from the 20 rats in each treatment group were combined and randomly mixed to ensure unbiased analysis. Midslice stroke area was the average of that measured for the two faces of each slice. The areas of cortical and caudate infarcts were measured separately. Infarct area was expressed in absolute terms as square millimeters and as a percentage of the total hemisphere area. Since each slice was 1 mm thick, the total infarct volume in cubic millimeters was numerically equivalent to the sum of the infarct areas of the 10 slices. Hemisphere volume was similarly determined.
Unstained tissue was not usually seen anterior or posterior to the area of slicing. Sham-occluded rats showed uniform staining in both hemispheres.
Differences between mean values for each group were evaluated using one-tailed tests. Since we did not know whether the data could be described by a normal distribution, we analyzed the results using both Student's / test, which assumes a normal distribution, and Wilcoxon's rank sum test, which does not require a normal distribution. In general, the level of significance between the control and treated groups was slightly less for Wilcoxon's rank sum test and, therefore, this was used as the principal statistical test.
AP, TTC, sodium fluorescein, and mediumviscosity CMC were obtained from Sigma Chemical Co., St. Louis, Missouri. DMTU was purchased from Aldrich Chemical Co., Milwaukee, Wisconsin. 
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Results We monitored blood pressure, rectal temperature, hematocrit, serum osmolality, and arterial blood gases during the final 30 minutes before decapitating the rats. There were no significant differences in any of these physiological parameters between corresponding vehicle-and drug-treated groups.
As demonstrated by several other investigators, 20 -22 TTC sharply delineated an area of brain injury corresponding to the expected zone of cerebral ischemia following MCAO in rats (Figure 1 ). Planimetric analysis of the unstained tissue indicated that DMTU-treated rats at 24 hours and AP-treated rats at both 3 and 24 hours of ischemia showed reduced average stroke areas compared with their corresponding control groups in each of the 10 brain slices examined (Figure 2) . Overall, the volume of infarcted tissue was significantly reduced by 30% with DMTU treatment and by 35% and 32% at 3 and 24 hours, respectively, with AP treatment (Table 1 ). The total hemisphere volume was also significantly reduced by DMTU treatment, and AP treatment prevented the significant (p<0.02) increase in hemisphere volume that was observed between 3 and 24 hours of ischemia. Taken together, these results indicate that both DMTU and AP Allopurinol, 3 hr reduce not only stroke size but also the extent of brain edema accumulation that occurs during the first 24 hours of ischemia. The results shown in Figure 3 indicate that for both DMTU and AP treatment, stroke volume at 24 hours was reduced to a larger extent in the cortex. The smaller reduction in stroke size that occurred in the caudate at 24 hours was significant in the AP-treated but not the DMTU-treated rats. After was less than at 24 hours, and the protection provided by AP appeared greater. The ability of fluorescein to penetrate the BBB was investigated in a subgroup of AP-treated rats. The total volume of brain showing enhanced fluorescein uptake at 3 hours in the vehicle-treated rats was the same as that which failed to stain with TTC (Table 1) . AP treatment resulted in an even greater reduction in fluorescein uptake than it did in stroke volume. Although fluorescein is often used to delineate areas of brain in which the BBB has been destroyed, its normally low brain uptake may be due in part to energy-dependent active transport of fluorescein out of the brain. 23 Thus, increased fluorescein uptake could indicate either a breakdown of the BBB or a reduction in the rate of fluorescein efflux from brain. In either case, our results suggest that AP treatment preserves BBB function and reduces infarct size in continuous cerebral ischemia.
Discussion
Our results demonstrate a 30-35% reduction in infarct size following pretreatment with the hydroxyl radical scavenger DMTU or the xanthine oxidase inhibitor AP. After 24 hours, cortical areas are more effectively protected by both drugs than is the caudate. Furthermore, the reduction in stroke size is associated with a preservation of BBB function.
We chose DMTU and AP not only for their specific actions but also for their pharmacologic properties. The inability of certain free radical scavengers such as superoxide dismutase and catalase to cross the BBB is a serious obstacle to their use as cerebral protectors. In contrast, AP enters the brain 24 as a result of its affinity for the adenine transporter in brain capillaries, 12 and DMTU enters the brain because of its lipid solubility. 25 These drugs also have relatively long serum half-lives 10 -26 ; therefore, their beneficial effects can be expected to persist for 24 hours without retreatment. In most studies, AP is administered for several days before creation of ischemia because its metabolite, oxypurinol, is a more potent xanthine oxidase inhibitor, 27 and several days are required to achieve a steadystate level of oxypurinol in blood.
Free radicals arise as by-products of normal metabolism in most cells. Prostaglandin and leukotriene synthesis as well as activity of the mitochondrial electron transport chain normally produce reactive oxygen species. In settings of ischemiareperfusion, superoxide production by these pathways increases. 2 In addition, lipid peroxidation is initiated with secondary radical production. Further, as shown by McCord, 1 xanthine dehydrogenase is converted to xanthine oxidase and, in this form, is an important free radical generator. Under ischemic conditions, therefore, a number of putative free radical-generating systems exist.
McCord' and others 1011 have presented evidence that the xanthine oxidase system is the primary source of free radicals in settings of ischemiareperfusion. Protection has been demonstrated in multiple organ systems. The degree of protection is similar in animals pretreated with the xanthine oxidase inhibitor AP and in those receiving direct free radical scavengers such as superoxide dismutase, catalase, and DMTU. However, xanthine oxidase may not be equally important in all species. For example, Downey et al 28 recently demonstrated protection by superoxide dismutase in a rabbit heart model of ischemia-reperfusion that is not protected by AP pretreatment; however, rabbits contain no demonstrable cardiac xanthine oxidase activity. Regardless of the particular generator involved, it appears that free radical-induced injury is an important component of ischemic injury. Consequently, treatment with appropriate scavengers may be expected to limit tissue death.
The initial products of the above reactions are superoxide and hydrogen peroxide. These compounds may combine in a trace metal-catalyzed reaction to produce the hydroxyl radical, which is more reactive than either of its precursors. 29 In our rat MCAO model, reduction in stroke volume at 24 hours was similar following pretreatment with the hydroxyl scavenger DMTU and the xanthine oxidase inhibitor AP. This similarity suggests that xanthine oxidase is the primary free radical generator and that the hydroxyl radical is the primary mediator of tissue injury in ischemic rat brain.
Xanthine dehydrogenase activity is present in rat brain, and xanthine dehydrogenase is converted to xanthine oxidase during ischemia. 30 Uric acid, the product of the reaction xanthine oxidase catalyzes, accumulates in ischemic rat brain. 31 Further, xanthine oxidase is enriched in rat brain capillaries relative to whole brain. 12 Therefore, in addition to reducing generalized free radical injury, inhibiting xanthine oxidase could be expected to specifically preserve capillary function. Our results suggest that AP treatment resulted in reduced edema formation. Overall hemisphere volume did not increase between 3 and 24 hours in treated rats; during the same period, control rats had a 6% increase in hemisphere volume. A similar observation was made by Itoh et al 17 in an ischemia-reperfusion model in hypertensive rats. In their model, pretreatment with AP resulted in reduced sodium and water contents in cortical samples. Lo et al 32 proposed a primary role for the capillaries in ischemic cerebral edema formation. Thus, reduced edema formation following AP treatment and reduced brain fluorescein uptake may be secondary to improved capillary function.
As shown in Figure 1 , MCAO results in ischemic damage primarily to the lateral caudate and cerebral cortex. The branches of the MCA that supply the cortex have extensive anastomoses with distal branches of the anterior and posterior cerebral arteries. 33 Interarterial anastomoses between the distal branches of these vessels that supply the caudate nucleus have not been described. 34 - 35 We hypothesize that free radicals were acting to prevent the establishment and/or maintenance of collateral blood supply; therefore, in rats subjected to MCAO, drug treatment would prevent damage only in brain regions in which collateral blood supply was available. Consequently, we would expect cerebral protection to occur primarily in the cortex and not in the caudate. This hypothesis is supported by the results that we obtained at 24 hours but not by those we obtained at 3 hours.
Selman et al 36 recently studied the relation between blood flow and energy charge of cerebral tissue in the rat MCAO model. They defined three zones: a medial area in which blood flow and energy charge are near normal, a lateral zone in which blood flow is minimal and metabolic activity is virtually nonexistent, and an intermediate zone of variable blood flow and metabolic activity. Careful analysis of tissue in this intermediate zone showed a spectrum of energy charge. Tissue at the lateral margin of the intermediate zone showed severe metabolic compromise. Selman et al 36 suggested that this lateral margin was unlikely to survive unless blood flow could be improved. In our study, AP pretreatment had the following effects. Protection at 3 hours was significant in the caudate, a region supplied primarily by end arteries. At 24 hours, however, protection was greater in the cortex, a region supplied by collaterals from the anterior and posterior cerebral circulations. While infarct volume more than doubled in the caudate between 3 and 24 hours, it was unchanged in the cortex. These results are consistent with the proposal of protection at the intermediate zone. That is, free radical scavengers were able to slow infarct progression in a zone of low blood flow, the caudate; however, in the absence of some minimal blood flow, absolute protection was limited. In the cortex, a region of greater collateral blood supply, protection was greater. We propose, therefore, that free radical scavengers may act to preserve tissue at blood flow levels below those usually associated with tissue death. This effect could be produced by protecting tissue directly or by protecting capillaries, with a resultant preservation of blood flow.
